Eudaimonia Partners, LLC Dexcom Inc Transaction History

Eudaimonia Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $3,320 - $4,425	-41 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $1,865 - $2,304	-22 Reduced 34.92%	41 $15,000
Q4 2020 Feb 18, 2021	SELL	$78.0 - $104.5 $702 - $940	-9 Reduced 12.5%	63 $23,000
Q3 2020 Nov 23, 2020	SELL	$95.51 - $112.95 $98,279 - $116,225	-1,029 Reduced 93.46%	72 $30,000
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $98,279 - $116,225	1,029 Added 1429.17%	1,101 $20,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $4,512 - $7,584	72 New	72 $29,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.